Gastric ulcers, a persistent health issue, have a significant likelihood of recurring and can lead to unexpected complications like bleeding, narrowing, and perforation. In recent decades, advancements in clinical treatments for gastric ulcers have enabled the swift creation of potent anti-ulcer drugs. While traditional treatments for gastric ulcers, including H2-receptor antagonists, are effective, proton pump inhibitors (PPIs) play an essential role in promoting ulcer healing and avoiding complications. Despite the progress made, some patients continue to experience recurrence or persistent issues even with ongoing anti-ulcer treatments. A novel concept known as the quality of ulcer healing (QOUH) was developed, focusing on restoring the mucosal structure and function to help prevent the return of ulcers. While various gastro protective measures have contributed to the successes of QOUH, we discovered that natural product-based gastro protection, particularly a new formulation derived from Artemisia or S-allyl cysteine from garlic, demonstrated significant effectiveness in QOUH, alongside alleviating clinical symptoms with reduced side effects. This review will highlight the significance of QOUH in ulcer healing and the advancements gained from natural products. Reduced side effects, even though various gastro protective measures have contributed to the success of QOUH.
Introduction
The terminology for wounds linked to chronic illnesses has evolved; such wounds are now referred to as complicated ulcers, not just complicated wounds.
Key characteristics of complicated ulcers:
Ulcers that do not improve after three months.
Presence of infection.
Reduced tissue viability due to necrosis or poor circulation.
Connection to systemic conditions that impair healing.
Diabetes is a leading cause, with diabetic foot ulcers (DFUs) being a major subtype.
Global diabetes prevalence: 6.3%, highest in North America (13%) and lowest in Oceania (3%).
Diabetic foot ulcers are a significant cause of non-traumatic lower limb amputations:
15% of DFU patients require amputation.
25% of diabetic patients experience ulcers in their lifetime.
2. Types of Ulcers
A. Peptic Ulcers by Location:
Gastric, duodenal, and esophageal ulcers.
B. Leg and Foot Ulcers:
Venous ulcers: poor blood return to the heart.
Arterial ulcers: poor blood supply to tissues.
Diabetic foot ulcers: circulation and nerve damage.
C. Other Ulcers:
Skin ulcers: pressure ulcers, lichen planus.
Mouth ulcers (canker sores).
Genital ulcers.
Corneal ulcers: infection or inflammation of the cornea.
3. Causes of Ulcers
Common Causes:
H. pylori infection.
NSAID use (ibuprofen, aspirin).
Other Causes:
Medications (corticosteroids, antidepressants).
Severe illnesses (Crohn’s disease, cancer, burns).
Factors worsening symptoms:
Stress, spicy foods, alcohol, caffeine—do not cause ulcers but exacerbate symptoms.
4. Diabetic Foot Ulcers (DFUs)
DFUs are a severe complication of diabetes, leading to infection, gangrene, sepsis, and amputation.
Antacids: effective in duodenal ulcer healing but not symptom reduction.
Endovenous ablation: effective for resistant venous ulcers.
Plant-based therapies: aloe, licorice, flavonoids show potential but limited clinical evidence.
Vitamin U, Belladonna, Aluminum + Omeprazole: improves healing, reduces recurrence, and increases H. pylori eradication.
C. Mouth Ulcers
Vitamin B complex (B1, B2, B3, B5, B6, B12, folic acid) supports tissue repair, enzyme activity, and red blood cell production, accelerating healing.
6. Research Approach
Systematic review using English and Persian sources over the past 20 years.
Databases: Google Scholar, PubMed, Science Direct, Magiran, Springer.
Conclusion
The significance of eradicating H pylori in cases of ulcer disease is clear, yet formulating a treatment strategy can be perplexing. Our review of the literature on eradication shows that 7–14-day treatment courses combining a proton pump inhibitor with clarithromycin and metronidazole are highly effective and generally well accepted. Vitamin B accelerates the healing of ulcers, lowers the chances of recurrence, and enhances the treatment\'s efficacy. Overall, vitamin B offers considerable clinical advantages for addressing mouth ulcers.
References
[1] Konturek, S.J., Konturek, P.C. and Brzozowski, T., 2005. Prostaglandins and ulcer healing. Journal of physiology and pharmacology, 56, p.5
[2] Szabo, S. and Vincze, Á., 2000. Growth factors in ulcer healing: lessons from recent studies. Journal of Physiology-Paris, 94(2), pp.77-81.
[3] Blum, A.L., 1985. Therapeutic approach to ulcer healing. The American Journal of Medicine, 79(2), pp.8-14.
[4] Peterson, W.L., Sturdevant, R.A., Frankl, H.D., Richardson, C.T., Isenberg, J.I., Elashoff, J.D., Sones, J.Q., Gross, R.A., McCallum, R.W. and Fordtran, J.S., 1977. Healing of duodenal ulcer with an antacid regimen. New England Journal of Medicine, 297(7), pp.341-345.
[5] Coleridge-Smith, P.D., 2009. Leg ulcer treatment. Journal of vascular surgery, 49(3), pp.804-808.
[6] Lawrence, P.F., Alktaifi, A., Rigberg, D., DeRubertis, B., Gelabert, H. and Jimenez, J.C., 2011. Endovenous ablation of incompetent perforating veins is effective treatment for recalcitrant venous ulcers. Journal of vascular surgery, 54(3), pp.737-742.
[7] Lavery, L.A., Peters, E.J. and Armstrong, D.G., 2008. What are the most effective interventions in preventing diabetic foot ulcers?. International wound journal, 5(3), pp.425-433.
[8] Fletcher, A., Cullum, N. and Sheldon, T.A., 1997. A systematic review of compression treatment for venous leg ulcers. Bmj, 315(7108), pp.576-580.
[9] Dharmani, P., Kuchibhotla, V.K., Maurya, R., Srivastava, S., Sharma, S. and Palit, G., 2004. Evaluation of anti-ulcerogenic and ulcer-healing properties of Ocimum sanctum Linn. Journal of ethnopharmacology, 93(2-3), pp.197-206.
[10] Meissner, M.H., 2014. Venous ulcer care: which dressings are cost effective?. Phlebology, 29(1_suppl), pp.174-180.
[11] Kashifard, M., Malekzadeh, R., Siavoshi, F., Mikaeli, J. and Massarrat, S., 1998. Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin. European journal of gastroenterology & hepatology, 10(10), pp.847-850.
[12] Gu, Y., Huang, Y., Qiu, Z., Xu, Z., Li, D., Chen, L., Jiang, J. and Gao, L., 2020. Vitamin B2 functionalized iron oxide nanozymes for mouth ulcer healing. Science China Life Sciences, 63(1), pp.68-79.
[13] Harnarayan, P., Ramdass, M.J., Maharaj, R. and Naraynsingh, V., 2016. Types of ulcers of lower extremity. In Ulcers of the Lower Extremity (pp. 15-38). New Delhi: Springer India.
[14] Yeomans, N.D., 2011. The ulcer sleuths: The search for the cause of peptic ulcers. Journal of gastroenterology and hepatology, 26, pp.35-41.
[15] Ågren, M.S., Eaglstein, W.H., Ferguson, M.W., Harding, K.G., Moore, K., Saarialho-Kere, U.K. and GS, S., 2000. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Dermato-Venereologica, 80, pp.3-17.
[16] Vaishnavi Burley, D., Biyani, D., Umekar, M. and Naidu, N., 2021. Medicinal plants for treatment of ulcer: A review. Journal of Medicinal Plants, 9(4), pp.51-59.
[17] Awaad, A.S., El-Meligy, R.M. and Soliman, G.A., 2013. Natural products in treatment of ulcerative colitis and peptic ulcer. Journal of Saudi chemical society, 17(1), pp.101-124.
[18] Cheney, G., 1952. Vitamin U therapy of peptic ulcer. California Medicine, 77(4), p.248.
[19] Chen HanLin, C.H., Li FaQuan, L.F. and Dong Lin, D.L., 2019. Clinical study on Vitamin U, Belladonna and Aluminium Capsules II combined with omeprazole in treatment of gastric ulcer.
[20] Raju, S., Kirk, O.K. and Jones, T.L., 2013. Endovenous management of venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 1(2), pp.165-172.